Changing Epidemiology of Invasive Mold Infections in Patients Receiving Azole Prophylaxis.

about

Recent advances in the understanding and management of mucormycosis Susceptibility Testing of Fungi to Antifungal Drugs

P2860

Q57116582-7A8877AB-78CA-4DB3-B068-2FB3C9989BE0 Q58737037-EF2436D7-2F3B-4D4A-B843-4F56571CF5A4

P2860

Changing Epidemiology of Invasive Mold Infections in Patients Receiving Azole Prophylaxis.

Item

http://www.wikidata.org/entity/Q38960267

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Changing Epidemiology of Invas ...... s Receiving Azole Prophylaxis.

@en

type

Item

label

Changing Epidemiology of Invas ...... s Receiving Azole Prophylaxis.

@en

prefLabel

Changing Epidemiology of Invas ...... s Receiving Azole Prophylaxis.

@en

P1476

Changing Epidemiology of Invas ...... s Receiving Azole Prophylaxis.

@en

P2093

Barbara D Alexander

http://www.w3.org/2001/XMLSchema#string

Lauro Damonti

http://www.w3.org/2001/XMLSchema#string

P2860

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis.

Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational s

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease.

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria.

Invasive Scopulariopsis brevicaulis infection in an immunocompromised patient and review of prior cases caused by Scopulariopsis and Microascus species.

A cohort study on breakthrough invasive fungal infections in high-risk patients receiving antifungal prophylaxis.

Epidemiology and outcomes of invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients in the era of antifungal prophylaxis: a single-centre study with focus on emerging pathogens.

Breakthrough invasive fungal disease in patients receiving posaconazole primary prophylaxis: a 4-year study.

P304

1619-1621

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CID/CIX130

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Frédéric Lamoth

Jasmine S Chung

P577

2017-02-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28199491

http://www.w3.org/2001/XMLSchema#string

Changing Epidemiology of Invasive Mold Infections in Patients Receiving Azole Prophylaxis.

about

P2860

P2860

Changing Epidemiology of Invasive Mold Infections in Patients Receiving Azole Prophylaxis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698